Biomea Fusion, Inc. (BMEA) stock

BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30

$0.56−0.05 (-7.89%)

Close on Nov 12, 2026Market cap $40.79MP/E –Yield –

Biomea Fusion revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2022	Sep 30, 2022	$165.00M	–
Q2 FY2022	Jun 30, 2022	$0	-100.0%
Q1 FY2022	Mar 31, 2022	$1.07B	–
Q3 FY2021	Sep 30, 2021	$0	–
Q2 FY2021	Jun 30, 2021	$0	–
Q1 FY2021	Mar 31, 2021	$1.07B	–

See a number that looks wrong?